Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Apr 28, 2025 - 17:21
 0
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion